Role of new Immunophenotypic Markers on Prognostic and Overall Survival of Acute Myeloid Leukemia: a Systematic Review and Meta-Analysis
2017 · Scientific Reports · 34 citations
https://doi.org/10.1038/s41598-017-00816-2
A
Alex Freire Sandes
Brf (Brazil)(BR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
1.1K
Citations
13
h-index
17
i10-index
Alex Freire Sandes is an academic researcher from Brf (Brazil). The author has contributed to research in topics: Acute Myeloid Leukemia Research & Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research. The author has an h-index of 13, co-authored 57 publications.
ORCID: 0000-0002-2502-4493Papers by this author
worksTranscriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism
2019 · Scientific Reports · 26 citations
https://doi.org/10.1038/s41598-018-38314-8
Rationale and design of the “Tocilizumab in patients with moderate to severe COVID-19: na open-label multicentre randomized controlled” trial (TOCIBRAS)
2020 · Revista Brasileira de Terapia Intensiva · 8 citations
https://doi.org/10.5935/0103-507x.20200060
Improving the outcomes of elderly patients with acute myeloid leukemia in a Brazilian University Hospital
2011 · Clinics · 7 citations
https://doi.org/10.1590/s1807-59322011000800005
Association of myelodysplastic syndrome with CD5+, CD23+ monoclonal B-cell lymphocytosis
2012 · Clinics · 4 citations
https://doi.org/10.6061/clinics/2012(12)22
Rationale and design of the “Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled” trial (TOCIBRAS)
2021 · Figshare · 1 citations
https://doi.org/10.6084/m9.figshare.14304338
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat